Why the study?
Does enteric-coated low-dose aspirin cause small intestinal perforation in patients with severe atherosclerosis under PPI administration?
Does enteric-coated low-dose aspirin cause small intestinal perforation in patients with severe atherosclerosis under PPI administration?
Enteric-coated low-dose aspirin may cause small intestinal perforation in patients with severe atherosclerosis receiving proton pump inhibitors.
Answers are grounded in this paper and cite their sources.
LDA may cause recurrent small-bowel perforation despite PPI; this Level-5 case leaves the association open for prospective confirmation.
A 77-year-old man presented with abdominal pain for 1 week. He was taking enteric-coated low-dose aspirin (LDA) to prevent secondary cardiovascular events and a proton pump inhibitor (PPI). Computed tomography indicated a small intestinal perforation; thus, small intestine resection was performed. Two months after surgery, he experienced a recurrence of the perforation. Since his repeated perforation was suspected to be due to LDA, LDA was discontinued. He has experienced no further recurrence since then. This is the first case of small intestinal perforation caused by enteric-coated LDA. Enteric-coated LDA may cause small intestinal perforation in patients with severe atherosclerosis under PPI administration.
No takes yet. Share an insight, caveat, or question.
Matsubara et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: